Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
Clinical trial NCT03417154 · COMPLETED
Trial details
- NCT number
- NCT03417154
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-13
- Primary completion
- 2022-01-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.